This case illustrates a rare instance of prostatic metastasis from EGFR-mutant lung adenocarcinoma and emphasizes the critical role of repeat biopsy, molecular profiling, and multidisciplinary evaluation in atypical metastatic presentations. The gene discussed is EGFR; the disease is lung adenocarcinoma.